Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance

被引:26
|
作者
Xu, Xiao-Xian [1 ,2 ]
Zhou, Jian-Song [1 ,3 ]
Yuan, Shu-Hui [1 ,2 ]
Yu, Hua [1 ,2 ]
Lou, Han-Mei [1 ,2 ]
机构
[1] Key Lab Radiat Oncol Zhejiang Prov, Hangzhou 310022, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Dept Gynecol Radiat Oncol, Hangzhou 310022, Zhejiang, Peoples R China
[3] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou 310022, Zhejiang, Peoples R China
关键词
HPV; vaccine; cervical; ICC; CIN; genotype; CANCER; PREVALENCE; RISK; PAPILLOMAVIRUSES; INFECTION; WOMEN;
D O I
10.3390/ijerph120910794
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Human papillomavirus (HPV) are firmly established as the principal causative agent for cervical carcinoma. Current vaccines may provide some protection for women from cervical carcinoma linked to HPV genotype 16 and 18. This may be the best vaccine for Western women, but the geographical variation in HPV distributions may not make it the most appropriate vaccine for China or Asia. This study provided an observational, retrospective, hospital-based cross-sectional study on the distribution of HPV genotypes among 5410 women with invasive cervical cancer (ICC) or cervical intraepithelial neoplasia (CIN). Overall, the positive rates of the four HPV types included in current prophylactic vaccines were counted, the two high-risk types (HPV-16 and -18) covered by current vaccines represented 66.9% of women with squamous cancer, 55.0% with adenocarcinoma, 64.9% with adenosquamous carcinoma and 77.4% of other type ICC, as well as 59.5% of CIN III, 45.0% of CIN II and 38.1% of CIN I cases. As expected, two low-risk types (HPV-6 and -11) included in the quadrivalent vaccine did not show good coverage data. Particularly worth mentioning is the fact that the addition of HPV-52 and -58 to the vaccine cocktail would increase cancer protection in our population, potentially preventing up to beyond 16% of squamous/adenosquamous carcinoma and other type of cervical cancers, and 7.75% of adenocarcinomas. It might also potentially reduce the rate of CIN III by a further 28.6% and CIN II and I by a third. This study established the baseline for surveillance in Zhejiang Province, and provides data for further vaccine designs: a quadrivalent HPV vaccine covering HPV-16/-58/-18/-52, would be more welcome in our region in the forthcoming year compared to the currently available vaccine.
引用
下载
收藏
页码:10794 / 10805
页数:12
相关论文
共 50 条
  • [31] HPV integration and methylation patterns in cervical intraepithelial neoplasia and invasive cervical cancer via HPV capture and high-throughput sequencing
    Iden, Marissa
    Fye, Samantha
    Huang, Yi-Wen
    Liu, Pengyuan
    Rader, Janet S.
    CANCER RESEARCH, 2014, 74 (19)
  • [32] HPV Prevalence and Cervical Intraepithelial Neoplasia among HIV-infected Women in Yunnan Province, China: A Pilot Study
    Zhang, Hong-Yun
    Tiggelaar, Sarah M.
    Sahasrabuddhe, Vikrant V.
    Smith, Jennifer S.
    Jiang, Cheng-Qin
    Mei, Run-Bo
    Wang, Xian-Guo
    Li, Zu-An
    Qiao, You-Lin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (01) : 91 - 96
  • [33] A comparison of cervical screening histories in women developing intraepithelial neoplasia and invasive carcinoma
    Morrison, I.
    Deery, A.
    JOURNAL OF PATHOLOGY, 2006, 210 : 58 - 58
  • [34] Prevalence and Genotype Distribution of HPV Types in Women at Risk for Cervical Neoplasia in Israel
    Siegler, Efraim
    Shiner, Maayan
    Segev, Yakir
    Mackuli, Lena
    Lahat, Nitza
    Lavie, Ofer
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (10): : 635 - 639
  • [35] From primary HPV infection to carcinoma in situ: A mathematical approach to cervical intraepithelial neoplasia
    Bitsouni, Vasiliki
    Gialelis, Nikolaos
    Stratis, Ioannis G.
    Tsilidis, Vasilis
    STUDIES IN APPLIED MATHEMATICS, 2024, 153 (02)
  • [36] p16INK4A Is a Strong Biomarker for Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma: A Reappraisal
    Haidopoulos, Dimitrios
    Partsinevelos, George A.
    Vlachos, George D.
    Rodolakis, Alexandros
    Markaki, Sonia
    Voulgaris, Zannis
    Diakomanolis, Emmanuel
    Antsaklis, Aris
    REPRODUCTIVE SCIENCES, 2009, 16 (07) : 685 - 693
  • [37] p16INK4A Is a Strong Biomarker for Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma: A Reappraisal
    Dimitrios Haidopoulos
    George A. Partsinevelos
    George D. Vlachos
    Alexandros Rodolakis
    Sonia Markaki
    Zannis Voulgaris
    Emmanuel Diakomanolis
    Aris Antsaklis
    Reproductive Sciences, 2009, 16 : 685 - 693
  • [38] Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
    Nygard, Mari
    Hansen, Bo Terning
    Dillner, Joakim
    Munk, Christian
    Oddsson, Kristjan
    Tryggvadottir, Laufey
    Hortlund, Maria
    Liaw, Kai-Li
    Dasbach, Erik J.
    Kjaer, Susanne Kruger
    PLOS ONE, 2014, 9 (02):
  • [39] Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma
    Guo, Ming
    Sneige, Nour
    Silva, Elvio G.
    Jan, Yee Jee
    Cogdell, David E.
    Lin, E.
    Luthra, Rajyalakshmi
    Zhang, Wei
    MODERN PATHOLOGY, 2007, 20 (02) : 256 - 266
  • [40] Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma
    Guo, M.
    Sneige, N.
    Zhang, W.
    Silva, E.
    Cogdell, D.
    Jan, Y. J.
    Lin, E.
    Luthra, R.
    MODERN PATHOLOGY, 2007, 20 : 199A - 199A